David D’Cruz

18.2k total citations · 2 hit papers
279 papers, 10.8k citations indexed

About

David D’Cruz is a scholar working on Rheumatology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David D’Cruz has authored 279 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 208 papers in Rheumatology, 66 papers in Immunology and 60 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David D’Cruz's work include Systemic Lupus Erythematosus Research (158 papers), Vasculitis and related conditions (49 papers) and Systemic Sclerosis and Related Diseases (33 papers). David D’Cruz is often cited by papers focused on Systemic Lupus Erythematosus Research (158 papers), Vasculitis and related conditions (49 papers) and Systemic Sclerosis and Related Diseases (33 papers). David D’Cruz collaborates with scholars based in United Kingdom, United States and Canada. David D’Cruz's co-authors include Munther A. Khamashta, Graham R.V. Hughes, Shirish Sangle, David Isenberg, Caroline Gordon, Pamela Lutalo, Ian N Bruce, Jennifer Hannah, Christos Lampropoulos and Bridget Griffiths and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

David D’Cruz

265 papers receiving 10.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors

2010 919 citations David D’Cruz et al. profile →
Systemic lupus erythematosus

2007 679 citations David D’Cruz, Munther A. Khamashta et al. profile →

Peers

Countries citing papers authored by David D’Cruz

Since Specialization

Citations

This map shows the geographic impact of David D’Cruz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David D’Cruz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David D’Cruz more than expected).

Fields of papers citing papers by David D’Cruz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David D’Cruz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David D’Cruz. The network helps show where David D’Cruz may publish in the future.

Co-authorship network of co-authors of David D’Cruz

This figure shows the co-authorship network connecting the top 25 collaborators of David D’Cruz. A scholar is included among the top collaborators of David D’Cruz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David D’Cruz. David D’Cruz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis 2024 ·The Journal of Allergy and Clinical Immunology In Practice ·Alexandra M. Nanzer, (unknown), (unknown), Linda K. Green, Louise Thomson, (unknown), Mariana Fernandes, Cris Roxas, G d’Ancona, A Hearn, (unknown), Sangita Agarwal, Brian D. Kent, (unknown), David D’Cruz, Claire Hopkins, Tevfik F. Ismail, Jaideep Dhariwal, David J. Jackson	13
2	Improving the arthritis component of the SLEDAI-2K 2024 ·Lara D. Veeken ·Khaled Mahmoud, Md Yuzaiful Md Yusof, Lee Suan Teh, Shah H.M. Khan, Chee‐Seng Yee, David D’Cruz, David Isenberg, Coziana Ciurtin, Philip G. Conaghan, Paul Emery, Christopher J Edwards, E. Hensor, Edward M Vital	1
3	Neuropsychiatric symptoms in systemic lupus erythematosus: mixed methods analysis of patient-derived attributional evidence in the international INSPIRE project 2024 ·Lara D. Veeken ·Melanie Sloan, Thomas Pollak, Efthalia Massou, Guy Leschziner, Laura Andréoli, Rupert Harwood, (unknown), Mervi Pitkänen, (unknown), Alessandra Bortoluzzi, Michael S. Zandi, (unknown), Caroline Gordon, David Jayne, Felix Naughton, (unknown), Chris Wincup, James Brimicombe, James A. Bourgeois, David D’Cruz	4
4	The HAVEN study—hydroxychloroquine in ANCA vasculitis evaluation—a multicentre, randomised, double-blind, placebo-controlled trial: study protocol and statistical analysis plan 2023 ·Trials ·(unknown), Lauren D. Arnold, Fiona Reid, (unknown), Alina Casian, Shirish Sangle, N S Morton, Louise Nel, (unknown), Susan John, Sangmi Kim, (unknown), Raashid Luqmani, David Jayne, James Galloway, Abdel Douiri, David D’Cruz, (unknown)	2
5	Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial data 2023 ·Lupus Science & Medicine ·David D’Cruz, (unknown), Yulia Green, Anne E. Hammer, Beulah Ji, (unknown), David A. Roth	3
6	Two subsets of human marginal zone B cells resolved by global analysis of lymphoid tissues and blood 2022 ·Science Immunology ·Jacqueline H. Y. Siu, Michael J. Pitcher, Thomas J Tull, (unknown), William Guesdon, Lucia Montorsi, Krishnaa T. Mahbubani, Richard J. Ellis, Pawan Dhami, (unknown), Ulrich D. Kadolsky, Michelle Kleeman, David D’Cruz, Kourosh Saeb‐Parsy, Mats Bemark, Gavin J. Pettigrew, Jo Spencer	39
7	Defective STAT5 Activation and Aberrant Expression of BCL6 in Naive CD4 T Cells Enhances Follicular Th Cell–like Differentiation in Patients with Granulomatosis with Polyangiitis 2022 ·The Journal of Immunology ·Sangmi Kim, Lena Boehme, Louise Nel, Alina Casian, Shirish Sangle, Estefanía Nova‐Lamperti, Vlad C. Seitan, Jo Spencer, Paul Lavender, David D’Cruz, Susan John	8
8	Respiratory subtype of relapsing polychondritis frequently presents as difficult asthma: a descriptive study of respiratory involvement in relapsing polychondritis with 13 patients from a single UK centre 2021 ·ERJ Open Research ·Shirish Dubey, Colin Gelder, (unknown), Asad Ali, Christopher Taylor, (unknown), (unknown), Patrick B. Murphy, Nicholas Hart, David D’Cruz	11
9	‘But you don’t look sick’: a qualitative analysis of the LUPUS UK online forum 2020 ·Rheumatology International ·Melanie Sloan, (unknown), (unknown), (unknown), (unknown), David D’Cruz, (unknown), Felix Naughton, Paul Howard, Stephen Sutton, Caroline Gordon	21
10	IgG4-related hypophysitis in adolescence 2020 ·Journal of Pediatric Endocrinology and Metabolism ·Ved Bhushan Arya, (unknown), (unknown), Zita Reisz, Bassel Zebian, David D’Cruz, Andrew King, (unknown), Simon Aylwin, Ritika R. Kapoor, Charles Buchanan	4
11	Cutaneous lupus erythematosus 2015 ·British Journal of Hospital Medicine ·Thomas J Tull, Andrew Pink, Emma Benton, David D’Cruz	3
12	Clinical guidelines for the management of acute viral infections in patients with systemic lupus erythematosus. 2009 ·PubMed ·Manuel Ramos‐Casals, M J Cuadrado, Paula Alba, Giovanni Sanna, Pilar Brito‐Zerón, María Laura Bertolaccini, Alejandra Babini, Ana Cristina Perez Moreno, David D’Cruz, Munther A. Khamashta	5
13	Acute manifestations of autoimmune connective tissue diseases 2006 ·British Journal of Hospital Medicine ·(unknown), David D’Cruz	1
14	Anabolic steroid-induced rhabdomyolysis 2005 ·British Journal of Hospital Medicine ·Rosemary Adamson, Curtis Rambaran, David D’Cruz	13
15	Paediatric rheumatology [271-278] 2004 ·Lara D. Veeken ·Alexander N. Bennett, (unknown), Jonathan D Rees, David D’Cruz, G R Hughes	0
16	Development of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosus 2004 ·Journal of Clinical Investigation ·Noritaka Oyama, Ien Chan, S. M. Neill, Andrew P. South, Fenella Wojnarowska, Yoshio Kawakami, David D’Cruz, (unknown), Graham J. Hughes, Balbir S. Bhogal, Fumio Kaneko, Martin M. Black, John A. McGrath	35
17	Mycophenolate mofetil: A potential treatment for reducing proteinuria associated with membranous lupus nephritis. 2003 ·Research Portal (King's College London) ·Michela Ferro, Mohammed Yousuf Karim, I C Abbs, David D’Cruz, Munther A. Khamashta, G R Hughes	3
18	Prevalence of hypertension in 600 patients with antiphospholipid syndrome. 2003 ·Research Portal (King's College London) ·Shirish Sangle, David D’Cruz, Munther A. Khamashta, (unknown)	2
19	THE ASSESSMENT OF AEROBIC CAPACITY IN A GROUP OF PATIENTS WITH SLE AND ITS ASSOCIATION WITH FATIGUE, SLEEP QUALITY AND DISEASE ACTIVITY 1998 ·Arthritis & Rheumatism ·C. M. Tench, (unknown), (unknown), Patrick White, David D’Cruz	6
20	Ear, nose, and throat symptoms in subacute Wegener's granulomatosis. 1989 ·BMJ ·David D’Cruz, Elaine Baguley, Ronald A. Asherson, Graham R.V. Hughes	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact